|
|
||||||||
CUTTING EDGE |


*
Rheumatology Section and
Department of Histopathology, Hammersmith Campus, Imperial College School of Medicine, London, United Kingdom; and
Department of Histopathology, Charing Cross Campus, Imperial College School of Medicine, London, United Kingdom
C1q-deficient (C1qa-/-) mice develop antinuclear Abs and glomerulonephritis (GN) characterized by multiple apoptotic bodies. To explore the contribution of C3 activation to the induction of spontaneous GN, C1qa-/- mice were crossed with factor B- and C2-deficient (H2-Bf/C2-/-) mice. GN was present in 64% of the 45 C1qa/H2-Bf/C2-/- mice compared with 8% of the 65 H2-Bf/C2-/- mice and none of the 24 wild-type controls. IgG was detected in the glomeruli of diseased C1qa/H2-Bf/C2-/- kidneys. However, glomerular staining for C3 was absent. Increased numbers of glomerular apoptotic bodies were detected in undiseased C1qa/H2-Bf/C2-/- kidneys. These findings support the hypothesis that C1q may play a role in the clearance of apoptotic cells without the necessity for C3 activation and demonstrate that the activation of C3 is not essential for the development of GN in this spontaneous model of lupus-like disease.
This article has been cited by other articles:
![]() |
Y. Chen, Y.-B. Park, E. Patel, and G. J. Silverman IgM Antibodies to Apoptosis-Associated Determinants Recruit C1q and Enhance Dendritic Cell Phagocytosis of Apoptotic Cells J. Immunol., May 15, 2009; 182(10): 6031 - 6043. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Sheerin, K. Abe, P. Risley, and S. H. Sacks Accumulation of Immune Complexes in Glomerular Disease Is Independent of Locally Synthesized C3 J. Am. Soc. Nephrol., March 1, 2006; 17(3): 686 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Bijl, E Reefman, G Horst, P C Limburg, and C G M Kallenberg Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement Ann Rheum Dis, January 1, 2006; 65(1): 57 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Quigg Complement and the Kidney J. Immunol., October 1, 2003; 171(7): 3319 - 3324. [Full Text] [PDF] |
||||
![]() |
U. Kishore, S. K. Gupta, M. V. Perdikoulis, M. S. Kojouharova, B. C. Urban, and K. B. M. Reid Modular Organization of the Carboxyl-Terminal, Globular Head Region of Human C1q A, B, and C Chains J. Immunol., July 15, 2003; 171(2): 812 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Mitchell, M. C. Pickering, J. Warren, L. Fossati-Jimack, J. Cortes-Hernandez, H. T. Cook, M. Botto, and M. J. Walport C1q Deficiency and Autoimmunity: The Effects of Genetic Background on Disease Expression J. Immunol., March 1, 2002; 168(5): 2538 - 2543. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Einav, O. O. Pozdnyakova, M. Ma, and M. C. Carroll Complement C4 Is Protective for Lupus Disease Independent of C3 J. Immunol., February 1, 2002; 168(3): 1036 - 1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Fonseca, P. M. Carpenter, M. Park, G. Palmarini, E. L. Nelson, and A. J. Tenner C1qRP, a myeloid cell receptor in blood, is predominantly expressed on endothelial cells in human tissue J. Leukoc. Biol., November 1, 2001; 70(5): 793 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Robson, H. T. Cook, M. Botto, P. R. Taylor, N. Busso, R. Salvi, C. D. Pusey, M. J. Walport, and K. A. Davies Accelerated Nephrotoxic Nephritis Is Exacerbated in C1q-Deficient Mice J. Immunol., June 1, 2001; 166(11): 6820 - 6828. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sekine, C. M. Reilly, I. D. Molano, G. Garnier, A. Circolo, P. Ruiz, V. M. Holers, S. A. Boackle, and G. S. Gilkeson Complement Component C3 Is Not Required for Full Expression of Immune Complex Glomerulonephritis in MRL/lpr Mice J. Immunol., May 15, 2001; 166(10): 6444 - 6451. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kamradt and N. A. Mitchison Tolerance and Autoimmunity N. Engl. J. Med., March 1, 2001; 344(9): 655 - 664. [Full Text] [PDF] |
||||
![]() |
Z. Chen, S. B. Koralov, and G. Kelsoe Complement C4 Inhibits Systemic Autoimmunity through a Mechanism Independent of Complement Receptors Cr1 and Cr2 J. Exp. Med., November 6, 2000; 192(9): 1339 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Taylor, A. Carugati, V. A. Fadok, H. T. Cook, M. Andrews, M. C. Carroll, J. S. Savill, P. M. Henson, M. Botto, and M. J. Walport A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo J. Exp. Med., August 7, 2000; 192(3): 359 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Pickering and M. J. Walport Links between complement abnormalities and systemic lupus erythematosus Rheumatology, February 1, 2000; 39(2): 133 - 141. [Full Text] [PDF] |
||||
![]() |
M. Salmon and C. Gordon The role of apoptosis in systemic lupus erythematosus Rheumatology, December 1, 1999; 38(12): 1177 - 1183. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |